StonvexLoading…
StonvexStonvexStonvexCore line items from WELL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.45B | $6.03B | $4.75B | $4.17B |
Operating Income | Not available | $524.44M | $350.05M | $173.06M |
Net Income | $961.84M | $972.86M | $358.14M | $160.57M |
EPS (Diluted) | $1.39 | $1.57 | $0.66 | $0.30 |
Total Assets | $67.30B | $51.04B | $44.01B | $37.89B |
Total Liabilities | $24.10B | $18.47B | $17.64B | $16.50B |
Cash & Equivalents | $5.03B | $3.51B | $1.99B | $631.68M |
Free Cash Flow OCF − CapEx | $1.83B | $1.40B | $1.08B | $852.69M |
Shares Outstanding | 696.51M | 635.29M | 564.24M | 490.51M |